[en] Cyst infection is a diagnostic challenge in patients with autosomal dominant polycystic kidney disease (ADPKD) because of the lack of specific manifestations and limitations of conventional imaging procedures. Still, recent clinical observations and series have highlighted common criteria for this condition. Cyst infection is diagnosed if confirmed by cyst fluid analysis showing bacteria and neutrophils, and as a probable diagnosis if all four of the following criteria are concomitantly met: temperature of >38 degrees C for >3 days, loin or liver tenderness, C-reactive protein plasma level of >5 mg/dL and no evidence for intracystic bleeding on computed tomography (CT). In addition, the elevation of serum carbohydrate antigen 19-9 (CA19-9) has been proposed as a biomarker for hepatic cyst infection. Positron-emission tomography after intravenous injection of 18-fluorodeoxyglucose, combined with CT, proved superior to radiological imaging techniques for the identification and localization of kidney and liver pyocyst. This review summarizes the attributes and limitations of these recent clinical, biological and imaging advances in the diagnosis of cyst infection in patients with ADPKD.
Disciplines :
Urology & nephrology
Author, co-author :
JOURET, François ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie
Lhommel, Renaud
Devuyst, Olivier
Annet, Laurence
Pirson, Yves
Hassoun, Ziad
Kanaan, Nada
Language :
English
Title :
Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities.
Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301
Sallée M, Rafat C, Zahar JR et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1183-1189
Christophe JL, van Ypersele de Strihou C, Pirson Y. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group. Nephrol Dial Transplant 1996; 11: 1271-1276
Jacquet A, Pallet N, Kessler M et al. Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int 2011; 24: 582-587
Jouret F, Lhommel R, Beguin C et al. Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1644-1650
Telenti A, Torres VE, Gross JB, Jr et al. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 1990; 65: 933-942
Kanaan N, Goffin E, Pirson Y et al. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2010; 55: 916-922
Waanders E, van Keimpema L, Brouwer JT et al. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease. Liver Int 2009; 29: 1389-1395
Gupta S, Seith A, Dhiman RK et al. CT of liver cysts in patients with autosomal dominant polycystic kidney disease. Acta Radiol 1999; 40: 444
Piccoli GB, Arena V, Consiglio V et al. Positron emission tomography in the diagnostic pathway for intracystic infection in ADPKD and 'cystic' kidneys. a case series. BMC Nephrol 2011; 12: 48
Migali G, Annet L, Lonneux M et al. Renal cyst infection in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2008; 23: 404-405
Ichioka K, Saito R, Matsui Y et al. Diffusion-weighted magnetic resonance imaging of infected renal cysts in a patient with polycystic kidney disease. Urology 2007; 70: 1219
Gilbert BR, Cerqueira MD, Eary JF et al. Indium-111 white blood cell scan for infectious complications of polycystic renal disease. J Nucl Med 1985; 26: 1283-1286
Sebrechts C, Biberstein M, Klein JL et al. Limitations of indium-111 leukocyte scanning in febrile renal transplant patients. AJR 1986; 146: 823-829
Mariani G, Bruselli L, Kuwert T et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 2010; 37: 1959-1985
Keidar Z, Gurman-Balbir A, Gaitini D et al. Fever of unknown origin: the role of 18F-FDG PET/CT. J NuclMed 2008; 49: 1980-1985
Boellaard R, O'Doherty MJ, Weber WA et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging. Eur J Nucl Med Mol Imaging 2010; 37: 181-200
Bleeker-Rovers CP, de Sevaux RG, van Hamersvelt HWet al. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 2003; 41: E18-E21
Bonsib SM. Renal cystic diseases and renal neoplasms: A minireview. Clin J Am Soc Nephrol 2009; 4: 1998-2007
Repko BM, Tulchinsky M. Increased F-18 FDG uptake in resolving atraumatic bilateral adrenal hemorrhage (hematoma) on PET/CT. Clin Nucl Med 2008; 33: 651-653
